{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:31:29Z","timestamp":1785803489639,"version":"3.56.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universitat de Valencia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Drug-induced liver injury (DILI) is a major clinical and regulatory challenge, with cholestasis representing a frequent mechanism of hepatotoxicity. Conventional two-dimensional (2D) hepatocyte cultures often fail to predict such effects, underscoring the need for advanced models that better replicate liver architecture and function. In this study, a three-dimensional (3D) model was developed by encapsulating HepaRG cells within type I collagen hydrogels to enhance functional maturation and reduce differentiation time compared to standard 2D cultures. The 3D HepaRG model maintained long-term viability and exhibited improved hepatic functions, including urea and albumin production, xenobiotic metabolism, and antioxidant defense, particularly after 14\u00a0days of culture with a reduced amount of DMSO (1%) compared to the standard 2D protocol. When incubated with cholestatic antibiotics, such as cloxacillin, flucloxacillin, and nafcillin, the 3D model reproduced cholestatic DILI features, showing increased cytotoxicity in the presence of bile acids and after prolonged exposure. Transcriptomic profiling revealed dose-dependent modulation of genes involved in bile acid homeostasis. A more in-depth analysis of cloxacillin-toxicity using RNA-seq revealed an altered expression of genes involved in bile acid metabolism, oxidative stress, and endoplasmic reticulum stress. Functionally, cloxacillin induced oxidative stress, mitochondrial dysfunction, and activation of apoptotic signaling pathways. Overall, the collagen hydrogel\u2013based 3D HepaRG model provided a robust and physiologically relevant platform for investigating antibiotic-induced cholestatic DILI and its underlying mechanisms, offering improved predictivity over traditional 2D systems and valuable potential for preclinical drug safety assessment.<\/jats:p>","DOI":"10.1007\/s00204-026-04324-z","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T19:28:54Z","timestamp":1773170934000},"page":"2559-2580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A collagen hydrogel\u2013based 3D Heparg model for enhanced hepatocyte function and assessment of cholestatic drug-induced liver injury"],"prefix":"10.1007","volume":"100","author":[{"given":"Enrique","family":"Timor-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1740-0874","authenticated-orcid":false,"given":"Laia","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2532-790X","authenticated-orcid":false,"given":"M. Teresa","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"6","key":"4324_CR1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ et al (2011) Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther 89(6):806\u2013815. https:\/\/doi.org\/10.1038\/clpt.2011.58","journal-title":"Clin Pharmacol Ther"},{"key":"4324_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/953714","volume":"2012","author":"MB Alam","year":"2012","unstructured":"Alam MB, Kadoura A, Sathaiah M (2012) A fatal case of nafcillin-induced hepatotoxicity: a case report and the literature review. Case Rep Med 2012:953714. https:\/\/doi.org\/10.1155\/2012\/953714","journal-title":"Case Rep Med"},{"issue":"1","key":"4324_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10517-016-3360-z","volume":"161","author":"AV Aleksandrova","year":"2016","unstructured":"Aleksandrova AV, Burmistrova OA, Fomicheva KA, Sakharov DA (2016) Maintenance of high cytochrome P450 expression in HepaRG cell spheroids in DMSO-free medium. Bull Exp Biol Med 161(1):120\u2013124. https:\/\/doi.org\/10.1007\/s10517-016-3360-z","journal-title":"Bull Exp Biol Med"},{"key":"4324_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-241071","author":"R Angheleanu","year":"2021","unstructured":"Angheleanu R, Swart JN (2021) Flucloxacillin-induced liver injury in elderly patient. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2020-241071","journal-title":"BMJ Case Rep"},{"issue":"1","key":"4324_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.105.006759","volume":"34","author":"C Aninat","year":"2006","unstructured":"Aninat C, Piton A, Glaise D et al (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34(1):75\u201383","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"4324_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/toxsci\/kfv159","volume":"148","author":"JA Barber","year":"2015","unstructured":"Barber JA, Stahl SH, Summers C et al (2015) Quantification of drug-induced inhibition of canalicular cholyl-l-lysyl-fluorescein excretion from hepatocytes by high content cell imaging. Toxicol Sci 148(1):48\u201359. https:\/\/doi.org\/10.1093\/toxsci\/kfv159","journal-title":"Toxicol Sci"},{"issue":"4","key":"4324_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/path.1397","volume":"200","author":"P Bedossa","year":"2003","unstructured":"Bedossa P, Paradis V (2003) Liver extracellular matrix in health and disease. J Pathol 200(4):504\u2013515. https:\/\/doi.org\/10.1002\/path.1397","journal-title":"J Pathol"},{"issue":"1","key":"4324_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01171-y","volume":"7","author":"A Burban","year":"2017","unstructured":"Burban A, Sharanek A, Hue R et al (2017) Penicillinase-resistant antibiotics induce non-immune-mediated cholestasis through HSP27 activation associated with PKC\/P38 and PI3K\/AKT signaling pathways. Sci Rep 7(1):1815. https:\/\/doi.org\/10.1038\/s41598-017-01171-y","journal-title":"Sci Rep"},{"key":"4324_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2017.11.017","volume":"115","author":"A Burban","year":"2018","unstructured":"Burban A, Sharanek A, Guguen-Guillouzo C, Guillouzo A (2018) Endoplasmic reticulum stress precedes oxidative stress in antibiotic-induced cholestasis and cytotoxicity in human hepatocytes. Free Radic Biol Med 115:166\u2013178. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.11.017","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"4324_CR10","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jhep.2015.07.016","volume":"63","author":"J Chai","year":"2015","unstructured":"Chai J, Cai SY, Liu X et al (2015a) Canalicular membrane MRP2\/ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis. J Hepatol 63(6):1440\u20131448. https:\/\/doi.org\/10.1016\/j.jhep.2015.07.016","journal-title":"J Hepatol"},{"issue":"3","key":"4324_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120055","volume":"10","author":"J Chai","year":"2015","unstructured":"Chai J, Feng X, Zhang L et al (2015b) Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction. PLoS ONE 10(3):e0120055. https:\/\/doi.org\/10.1371\/journal.pone.0120055","journal-title":"PLoS ONE"},{"issue":"1","key":"4324_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Richert L, Augustijns P, Annaert P (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicol Appl Pharmacol 274(1):124\u2013136. https:\/\/doi.org\/10.1016\/j.taap.2013.10.032","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"4324_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/cphy.c120023","volume":"3","author":"JY Chiang","year":"2013","unstructured":"Chiang JY (2013) Bile acid metabolism and signaling. Compr Physiol 3(3):1191\u20131212. https:\/\/doi.org\/10.1002\/cphy.c120023","journal-title":"Compr Physiol"},{"key":"4324_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2023.123047","volume":"342","author":"RR Chowdhury","year":"2024","unstructured":"Chowdhury RR, Rose S, Ezan F, Sovadinova I, Babica P, Langouet S (2024) Hepatotoxicity of cyanotoxin microcystin-LR in human: insights into mechanisms of action in the 3D culture model Hepoid-HepaRG. Environ Pollut 342:123047. https:\/\/doi.org\/10.1016\/j.envpol.2023.123047","journal-title":"Environ Pollut"},{"key":"4324_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/toxins16010054","author":"F Coulet","year":"2024","unstructured":"Coulet F, Coton M, Iperi C, Belinger Podevin M, Coton E, Hymery N (2024) Cytotoxic effects of major and emerging mycotoxins on HepaRG cells and transcriptomic response after exposure of spheroids to enniatins B and B1. Toxins (Basel). https:\/\/doi.org\/10.3390\/toxins16010054","journal-title":"Toxins (Basel)"},{"issue":"15","key":"4324_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2165\/00003088-200443150-00003","volume":"43","author":"J Dingemanse","year":"2004","unstructured":"Dingemanse J, van Giersbergen PL (2004) Clinical pharmacology of bosentan, a dual endothelin receptor antagonist. Clin Pharmacokinet 43(15):1089\u20131115. https:\/\/doi.org\/10.2165\/00003088-200443150-00003","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"4324_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1124\/dmd.110.033605","volume":"38","author":"MT Donato","year":"2010","unstructured":"Donato MT, Hallifax D, Picazo L et al (2010) Metabolite formation kinetics and intrinsic clearance of phenacetin, tolbutamide, alprazolam, and midazolam in adenoviral cytochrome P450-transfected HepG2 cells and comparison with hepatocytes and in vivo. Drug Metab Dispos 38(9):1449\u20131455. https:\/\/doi.org\/10.1124\/dmd.110.033605","journal-title":"Drug Metab Dispos"},{"key":"4324_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","volume":"1250","author":"MT Donato","year":"2015","unstructured":"Donato MT, Tolosa L, Gomez-Lechon MJ (2015) Culture and functional characterization of human hepatoma HepG2 cells. Methods Mol Biol 1250:77\u201393. https:\/\/doi.org\/10.1007\/978-1-4939-2074-7_5","journal-title":"Methods Mol Biol"},{"issue":"2","key":"4324_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcyt.2019.12.005","volume":"22","author":"MT Donato","year":"2020","unstructured":"Donato MT, Bolonio M, Cabezas E et al (2020) Improved in vivo efficacy of clinical-grade cryopreserved human hepatocytes in mice with acute liver failure. Cytotherapy 22(2):114\u2013121. https:\/\/doi.org\/10.1016\/j.jcyt.2019.12.005","journal-title":"Cytotherapy"},{"issue":"4","key":"4324_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00204-022-03236-y","volume":"96","author":"MT Donato","year":"2022","unstructured":"Donato MT, Jimenez N, Pelecha M, Tolosa L (2022) Oxidative-stress and long-term hepatotoxicity: comparative study in Upcyte human hepatocytes and hepaRG cells. Arch Toxicol 96(4):1021\u20131037. https:\/\/doi.org\/10.1007\/s00204-022-03236-y","journal-title":"Arch Toxicol"},{"key":"4324_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2025.154119","volume":"514","author":"A Drees","year":"2025","unstructured":"Drees A, Nassiri V, Tabernilla A et al (2025) Optimization of the drug-induced cholestasis index based on advanced modeling for predicting liver toxicity. Toxic 514:154119. https:\/\/doi.org\/10.1016\/j.tox.2025.154119","journal-title":"Toxic"},{"key":"4324_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152298","author":"H Dubois-Pot-Schneider","year":"2022","unstructured":"Dubois-Pot-Schneider H, Aninat C, Kattler K et al (2022) Transcriptional and epigenetic consequences of DMSO treatment on HepaRG cells. Cells. https:\/\/doi.org\/10.3390\/cells11152298","journal-title":"Cells"},{"issue":"10","key":"4324_CR23","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1111\/bcp.15445","volume":"88","author":"K Faragalla","year":"2022","unstructured":"Faragalla K, Lau H, Wang HL, Liu J (2022) Cloxacillin-induced acute vanishing bile duct syndrome: a case study and literature review. Br J Clin Pharmacol 88(10):4633\u20134638. https:\/\/doi.org\/10.1111\/bcp.15445","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"4324_CR24","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/s0022-3476(78)81251-7","volume":"93","author":"WE Feldman","year":"1978","unstructured":"Feldman WE, Nelson JD, Stanberry LR (1978) Clinical and pharmacokinetic evaluation of nafcillin in infants and children. J Pediatr 93(6):1029\u20131033. https:\/\/doi.org\/10.1016\/s0022-3476(78)81251-7","journal-title":"J Pediatr"},{"issue":"4","key":"4324_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jhep.2021.06.021","volume":"75","author":"JC Fernandez-Checa","year":"2021","unstructured":"Fernandez-Checa JC, Bagnaninchi P, Ye H et al (2021) Advanced preclinical models for evaluation of drug-induced liver injury\u2014consensus statement by the European drug-induced liver injury network [PRO-EURO-DILI-NET]. J Hepatol 75(4):935\u2013959. https:\/\/doi.org\/10.1016\/j.jhep.2021.06.021","journal-title":"J Hepatol"},{"issue":"1","key":"4324_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-020-00166-2","volume":"7","author":"JA Franzosa","year":"2021","unstructured":"Franzosa JA, Bonzo JA, Jack J et al (2021) High-throughput toxicogenomic screening of chemicals in the environment using metabolically competent hepatic cell cultures. Npj Syst Biology Applications 7(1):7. https:\/\/doi.org\/10.1038\/s41540-020-00166-2","journal-title":"Npj Syst Biology Applications"},{"issue":"7","key":"4324_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199370","volume":"13","author":"SJ Gardiner","year":"2018","unstructured":"Gardiner SJ, Drennan PG, Begg R et al (2018) In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances. PLoS ONE 13(7):e0199370. https:\/\/doi.org\/10.1371\/journal.pone.0199370","journal-title":"PLoS ONE"},{"issue":"1","key":"4324_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","volume":"19","author":"SX Ge","year":"2018","unstructured":"Ge SX, Son EW, Yao R (2018) iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics 19(1):534. https:\/\/doi.org\/10.1186\/s12859-018-2486-6","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"4324_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00204-019-02437-2","volume":"93","author":"E Gijbels","year":"2019","unstructured":"Gijbels E, Vilas-Boas V, Deferm N et al (2019) Mechanisms and in vitro models of drug-induced cholestasis. Arch Toxicol 93(5):1169\u20131186. https:\/\/doi.org\/10.1007\/s00204-019-02437-2","journal-title":"Arch Toxicol"},{"issue":"4","key":"4324_CR31","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00204-020-02691-9","volume":"94","author":"E Gijbels","year":"2020","unstructured":"Gijbels E, Vilas-Boas V, Annaert P, Vanhaecke T, Devisscher L, Vinken M (2020) Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol 94(4):1151\u20131172. https:\/\/doi.org\/10.1007\/s00204-020-02691-9","journal-title":"Arch Toxicol"},{"issue":"3","key":"4324_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.14740\/gr824w","volume":"10","author":"MV Guido","year":"2017","unstructured":"Guido MV, Jithpratuck W, Parks GE, Krishnaswamy G (2017) Nafcillin-induced allergic eosinophilic cholestatic hepatitis. Gastroenterol Res 10(3):202\u2013207. https:\/\/doi.org\/10.14740\/gr824w","journal-title":"Gastroenterol Res"},{"issue":"1","key":"4324_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/toxsci\/kft021","volume":"133","author":"P Gunness","year":"2013","unstructured":"Gunness P, Mueller D, Shevchenko V, Heinzle E, Ingelman-Sundberg M, Noor F (2013) 3d organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci 133(1):67\u201378. https:\/\/doi.org\/10.1093\/toxsci\/kft021","journal-title":"Toxicol Sci"},{"issue":"9","key":"4324_CR34","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s00204-022-03329-8","volume":"96","author":"MM Hammour","year":"2022","unstructured":"Hammour MM, Othman A, Aspera-Werz R et al (2022) Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations. Arch Toxicol 96(9):2511\u20132521. https:\/\/doi.org\/10.1007\/s00204-022-03329-8","journal-title":"Arch Toxicol"},{"key":"4324_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep35434","volume":"6","author":"DF Hendriks","year":"2016","unstructured":"Hendriks DF, Fredriksson Puigvert L, Messner S, Mortiz W, Ingelman-Sundberg M (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434. https:\/\/doi.org\/10.1038\/srep35434","journal-title":"Sci Rep"},{"issue":"10","key":"4324_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.biocel.2011.06.011","volume":"43","author":"R Hoekstra","year":"2011","unstructured":"Hoekstra R, Nibourg GA, van der Hoeven TV et al (2011) The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol 43(10):1483\u20131489. https:\/\/doi.org\/10.1016\/j.biocel.2011.06.011","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"4324_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2133\/dmpk.18.16","volume":"18","author":"M Horikawa","year":"2003","unstructured":"Horikawa M, Kato Y, Tyson CA, Sugiyama Y (2003) Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet 18(1):16\u201322. https:\/\/doi.org\/10.2133\/dmpk.18.16","journal-title":"Drug Metab Pharmacokinet"},{"issue":"7","key":"4324_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1124\/dmd.107.020016","volume":"36","author":"KP Kanebratt","year":"2008","unstructured":"Kanebratt KP, Andersson TB (2008) Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos 36(7):1444\u20131452. https:\/\/doi.org\/10.1124\/dmd.107.020016","journal-title":"Drug Metab Dispos"},{"issue":"D1","key":"4324_CR39","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","volume":"49","author":"M Kanehisa","year":"2021","unstructured":"Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M (2021) KEGG: integrating viruses and cellular organisms. Nucleic Acids Res 49(D1):D545\u2013D551. https:\/\/doi.org\/10.1093\/nar\/gkaa970","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"4324_CR40","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.tiv.2007.03.022","volume":"21","author":"A Lahoz","year":"2007","unstructured":"Lahoz A, Donato MT, Picazo L, Gomez-Lechon MJ, Castell JV (2007) Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry. Toxicol in Vitro 21(7):1247\u20131252","journal-title":"Toxicol in Vitro"},{"issue":"17","key":"4324_CR41","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","volume":"287","author":"KE Lasser","year":"2002","unstructured":"Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH (2002) Timing of new black box warnings and withdrawals for prescription medications. JAMA 287(17):2215\u20132220. https:\/\/doi.org\/10.1001\/jama.287.17.2215","journal-title":"JAMA"},{"issue":"1","key":"4324_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/toxsci\/kfs232","volume":"130","author":"SB Leite","year":"2012","unstructured":"Leite SB, Wilk-Zasadna I, Zaldivar JM et al (2012) Three-dimensional HepaRG model as an attractive tool for toxicity testing. Toxicol Sci 130(1):106\u2013116","journal-title":"Toxicol Sci"},{"key":"4324_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/polym14091923","author":"FC Liao","year":"2022","unstructured":"Liao FC, Wang YK, Cheng MY, Tu TY (2022) A preliminary investigation of embedding in vitro HepaRG spheroids into recombinant human collagen type I for the promotion of liver differentiation. Polymers. https:\/\/doi.org\/10.3390\/polym14091923","journal-title":"Polymers"},{"issue":"Suppl 1","key":"4324_CR44","first-page":"1","volume":"26","author":"J Mensa","year":"2013","unstructured":"Mensa J, Soriano A, Llinares P et al (2013) Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus. Rev Esp Quimioter 26(Suppl 1):1\u201384","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"4324_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tiv.2013.06.024","volume":"28","author":"D Mueller","year":"2014","unstructured":"Mueller D, Kramer L, Hoffmann E, Klein S, Noor F (2014) 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol in Vitro 28(1):104\u2013112. https:\/\/doi.org\/10.1016\/j.tiv.2013.06.024","journal-title":"Toxicol in Vitro"},{"issue":"1","key":"4324_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cbi.2004.09.003","volume":"150","author":"PJ O'Brien","year":"2004","unstructured":"O\u2019Brien PJ, Chan K, Silber PM (2004) Human and animal hepatocytes in vitro with extrapolation in vivo. Chem Biol Interact 150(1):97\u2013114. https:\/\/doi.org\/10.1016\/j.cbi.2004.09.003","journal-title":"Chem Biol Interact"},{"issue":"3\u20134","key":"4324_CR47","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbrc.2011.11.032","volume":"416","author":"E Ogimura","year":"2011","unstructured":"Ogimura E, Sekine S, Horie T (2011) Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem Biophys Res Commun 416(3\u20134):313\u2013317. https:\/\/doi.org\/10.1016\/j.bbrc.2011.11.032","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"4324_CR48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3109\/10408444.2016.1149452","volume":"46","author":"IJ Onakpoya","year":"2016","unstructured":"Onakpoya IJ, Heneghan CJ, Aronson JK (2016) Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis. Crit Rev Toxicol 46(6):477\u2013489. https:\/\/doi.org\/10.3109\/10408444.2016.1149452","journal-title":"Crit Rev Toxicol"},{"key":"4324_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.vascn.2015.03.002","volume":"73","author":"M Oorts","year":"2015","unstructured":"Oorts M, Richert L, Annaert P (2015) Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture. J Pharmacol Toxicol Methods 73:63\u201371. https:\/\/doi.org\/10.1016\/j.vascn.2015.03.002","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"8","key":"4324_CR50","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00204-014-1320-9","volume":"89","author":"SP Rebelo","year":"2015","unstructured":"Rebelo SP, Costa R, Estrada M, Shevchenko V, Brito C, Alves PM (2015) HepaRG microencapsulated spheroids in DMSO-free culture: novel culturing approaches for enhanced xenobiotic and biosynthetic metabolism. Arch Toxicol 89(8):1347\u20131358. https:\/\/doi.org\/10.1007\/s00204-014-1320-9","journal-title":"Arch Toxicol"},{"issue":"1","key":"4324_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00204-021-03178-x","volume":"96","author":"S Rose","year":"2022","unstructured":"Rose S, Cuvellier M, Ezan F et al (2022) DMSO-free highly differentiated HepaRG spheroids for chronic toxicity, liver functions and genotoxicity studies. Arch Toxicol 96(1):243\u2013258. https:\/\/doi.org\/10.1007\/s00204-021-03178-x","journal-title":"Arch Toxicol"},{"issue":"30","key":"4324_CR52","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","volume":"877","author":"M Scherer","year":"2009","unstructured":"Scherer M, Gnewuch C, Schmitz G, Liebisch G (2009) Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877(30):3920\u20133925. https:\/\/doi.org\/10.1016\/j.jchromb.2009.09.038","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"4324_CR53","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","volume":"141","author":"A Sharanek","year":"2014","unstructured":"Sharanek A, Azzi PB, Al-Attrache H et al (2014) Different dose-dependent mechanisms are involved in early cyclosporine a-induced cholestatic effects in hepaRG cells. Toxicol Sci 141(1):244\u2013253. https:\/\/doi.org\/10.1093\/toxsci\/kfu122","journal-title":"Toxicol Sci"},{"issue":"2","key":"4324_CR54","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","volume":"147","author":"A Sharanek","year":"2015","unstructured":"Sharanek A, Burban A, Humbert L et al (2015) Cellular accumulation and toxic effects of bile acids in Cyclosporine A-treated HepaRG hepatocytes. Toxicol Sci 147(2):573\u2013587. https:\/\/doi.org\/10.1093\/toxsci\/kfv155","journal-title":"Toxicol Sci"},{"issue":"2","key":"4324_CR55","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/s0016-5085(00)70224-1","volume":"118","author":"B Stieger","year":"2000","unstructured":"Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ (2000) Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118(2):422\u2013430. https:\/\/doi.org\/10.1016\/s0016-5085(00)70224-1","journal-title":"Gastroenterology"},{"issue":"14","key":"4324_CR56","doi-asserted-by":"publisher","first-page":"13953","DOI":"10.1074\/jbc.M312170200","volume":"279","author":"E Szczesna-Skorupa","year":"2004","unstructured":"Szczesna-Skorupa E, Chen CD, Liu H, Kemper B (2004) Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome p450 overproduction. J Biol Chem 279(14):13953\u201313961. https:\/\/doi.org\/10.1074\/jbc.M312170200","journal-title":"J Biol Chem"},{"issue":"2","key":"4324_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.14573\/altex.2206201","volume":"40","author":"A Thienpont","year":"2023","unstructured":"Thienpont A, Verhulst S, Van Grunsven LA, Rogiers V, Vanhaecke T, Mertens B (2023) Novel prediction models for genotoxicity based on biomarker genes in human HepaRG cells. Altex 40(2):271\u2013286. https:\/\/doi.org\/10.14573\/altex.2206201","journal-title":"Altex"},{"issue":"1","key":"4324_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Pinto S, Donato MT et al (2012) Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci 127(1):187\u2013198. https:\/\/doi.org\/10.1093\/toxsci\/kfs083","journal-title":"Toxicol Sci"},{"key":"4324_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","volume":"302","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, Gomez-Lechon MJ, Jimenez N, Hervas D, Jover R, Donato MT (2016a) Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol 302:1\u20139. https:\/\/doi.org\/10.1016\/j.taap.2016.04.007","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"4324_CR60","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/toxsci\/kfw078","volume":"152","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, Gomez-Lechon MJ, Lopez S et al (2016b) Human Upcyte hepatocytes: characterization of the hepatic phenotype and evaluation for acute and long-term hepatotoxicity routine testing. Toxicol Sci 152(1):214\u2013229. https:\/\/doi.org\/10.1093\/toxsci\/kfw078","journal-title":"Toxicol Sci"},{"issue":"2","key":"4324_CR61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00204-018-2349-y","volume":"93","author":"L Tolosa","year":"2019","unstructured":"Tolosa L, Jimenez N, Pelecha M, Castell JV, Gomez-Lechon MJ, Donato MT (2019) Long-term and mechanistic evaluation of drug-induced liver injury in Upcyte human hepatocytes. Arch Toxicol 93(2):519\u2013532. https:\/\/doi.org\/10.1007\/s00204-018-2349-y","journal-title":"Arch Toxicol"},{"issue":"1","key":"4324_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.toxlet.2015.04.014","volume":"236","author":"T Tomida","year":"2015","unstructured":"Tomida T, Okamura H, Satsukawa M, Yokoi T, Konno Y (2015) Multiparametric assay using HepaRG cells for predicting drug-induced liver injury. Toxicol Lett 236(1):16\u201324. https:\/\/doi.org\/10.1016\/j.toxlet.2015.04.014","journal-title":"Toxicol Lett"},{"issue":"3","key":"4324_CR63","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner M, Zollner G, Trauner M (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51(3):565\u2013580. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.012","journal-title":"J Hepatol"},{"key":"4324_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109010","volume":"116","author":"ZY Wang","year":"2019","unstructured":"Wang ZY, Li WJ, Li QG et al (2019) A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro. Biomed Pharmacother 116:109010. https:\/\/doi.org\/10.1016\/j.biopha.2019.109010","journal-title":"Biomed Pharmacother"},{"key":"4324_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153256","volume":"476","author":"Y Wen","year":"2022","unstructured":"Wen Y, Zhang G, Wu X (2022) The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury. Toxicology 476:153256. https:\/\/doi.org\/10.1016\/j.tox.2022.153256","journal-title":"Toxicology"},{"issue":"9","key":"4324_CR66","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/jac\/dkx183","volume":"72","author":"K Wing","year":"2017","unstructured":"Wing K, Bhaskaran K, Pealing L et al (2017) Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother 72(9):2636\u20132646. https:\/\/doi.org\/10.1093\/jac\/dkx183","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"4324_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tiv.2009.08.009","volume":"24","author":"KK Wolf","year":"2010","unstructured":"Wolf KK, Vora S, Webster LO, Generaux GT, Polli JW, Brouwer KL (2010) Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transport. Toxicol in Vitro 24(1):297\u2013309. https:\/\/doi.org\/10.1016\/j.tiv.2009.08.009","journal-title":"Toxicol in Vitro"},{"issue":"5","key":"4324_CR68","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1159\/000494790","volume":"50","author":"B Yu","year":"2018","unstructured":"Yu B, Jin GN, Ma M et al (2018) Taurocholate induces connective tissue growth factor expression in hepatocytes through ERK-YAP signaling. Cell Physiol Biochem 50(5):1711\u20131725. https:\/\/doi.org\/10.1159\/000494790","journal-title":"Cell Physiol Biochem"},{"issue":"12","key":"4324_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05444-x","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Guo J, Yang N, Huang Y, Hu T, Rao C (2022) Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis 13(12):1051. https:\/\/doi.org\/10.1038\/s41419-022-05444-x","journal-title":"Cell Death Dis"},{"issue":"3","key":"4324_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M, Trauner M (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3(3):231\u2013251. https:\/\/doi.org\/10.1021\/mp060010s","journal-title":"Mol Pharm"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04324-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:32:19Z","timestamp":1780083139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04324-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4324"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04324-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors do not declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}